<DOC>
	<DOCNO>NCT00385775</DOCNO>
	<brief_summary>This study design find maximum tolerated dose , safety toxicity profile , identify dose limit toxicity AEG35156 administer 2-hour infusion patient advance cancer .</brief_summary>
	<brief_title>Study XIAP Antisense Advanced Cancers</brief_title>
	<detailed_description>This Phase I study , single-arm , open-label , dose escalation study establish recommend dose activity AEG35156 administer 2-hour daily infusion 3 day initially follow weekly 2-hour intravenous infusion patient advance cancer . Subjects eligible study entry must prove advanced metastatic cancer refactory conventional treatment conventional therapy exists . The start dose fix dose 60 mg/day escalation step 50 100 % successive cohort . Approximately 30 patient enter study determine maximum tolerate dose .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>histologically proven diagnosis advance metastatic cancer ( include solid tumour lymphoma ) refractory conventional treatment , conventional therapy exist life expectancy least 12 week ECOG performance status 0 1 hematological biochemical index specify within one week prior treatment know bleed diathesis concurrent treatment anticoagulant primary brain tumour brain metastasis radiotherapy ( except palliative ) , endocrine therapy , immunotherapy chemotherapy previous four week ( six week nitrosoureas mitomycinC ) toxic manifestation previous treatment must resolve ( except alopecia certain Grade 1 toxicity ) pregnant lactate woman major thoracic and/or abdominal surgery precede 4 week high medical risk nonmalignant systemic disease include uncontrolled infection hepatitis B , C Human Immunodeficiency Virus allergic history antisense agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Cancer</keyword>
	<keyword>solid tumour</keyword>
	<keyword>refractory</keyword>
	<keyword>antisense</keyword>
	<keyword>oligonucleotide</keyword>
</DOC>